/PRNewswire/ Fresenius Medical Care North America s (FMCNA) Renal Therapies Group announced today that the U.S. Food and Drug Administration (FDA) has.
/PRNewswire/ Fresenius Medical North America s (FMCNA) Renal Therapies Group, the leading provider of kidney care products, will be a company of choice to.
/PRNewswire/ Fresenius Medical Care North America s (FMCNA) Renal Therapies Group today announced the availability of Speedswap®, a new option for the.